High Times
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

What's truly amazing is that for the last

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Here Today Member Profile
Member Level 
Followed By 21
Posts 2,678
Boards Moderated 0
Alias Born 01/05/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2018 4:17:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2018 6:20:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2018 10:56:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2018 6:54:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/9/2018 6:53:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:36:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:33:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2018 4:03:40 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2018 4:04:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2018 2:11:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/29/2018 7:24:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:14:20 PM
Traders News Issues Research on High Growth Canna and Pharma Stocks InvestorsHub NewsWire - 4/25/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2018 1:18:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 3:04:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
Here Today Member Level  Friday, 01/12/18 07:40:26 PM
Re: None
Post # of 245399 
What's truly amazing is that for the last 3 months (probably longer) all we have heard from the "Shorties" is about all the Dilution and how Leo has been hitting the Aspire funds. But if the figure of 40k+ in new outstanding shares is Factual, then I must commend Leo for his fiscal responsibility and looking after our investment. I do not care what anyone says, he has been doing a great job to minimize our debt which is imperative for a small Bio company. Our pipeline is stacked in my honest opinion and am excited for what's to come this year.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist